PTHS vs CLYM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

PTHS

44.8
AI Score
VS
PTHS Wins

CLYM

41.4
AI Score

Investment Advisor Scores

PTHS

45score
Recommendation
HOLD

CLYM

41score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric PTHS CLYM Winner
Net Income -43.32M -27.22M CLYM
Operating Income -32.43M -30.57M CLYM
ROE -111.4% -11.4% CLYM
ROA -33.2% -11.1% CLYM
Total Assets 130.40M 246.29M CLYM
Cash 17.97M 44.11M CLYM
Current Ratio 2.05 31.45 CLYM
Free Cash Flow -22.69M -25.18M PTHS

Relative Price Performance (Last 90 Days)

PTHS 1M: -24.2% · 3M: -23.7% CLYM 1M: -1.0% · 3M: +30.6%

Current Technical Phase

PTHS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.8%), weak momentum, RSI 32

RSI (14): 32.4 · Price: $21.90

CLYM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 45.8 · Price: $14.25

Fundamentals Snapshot

Metric PTHS CLYM
Market Cap
Forward P/E -3.9 -14.2
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 0.8%
Operating Margin -1.0% 0.0%
EPS -27.42 -0.82
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, PTHS is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.